123 related articles for article (PubMed ID: 9833191)
1. [Expression of CD44 and isoforms v4, v5, v6, v7, v10--new prognostic parameters in ductal pancreatic carcinoma?].
Böttger T; Maschek H; Gottwald W; Lobo M; Brenner W; Junginger T
Chirurg; 1998 Oct; 69(10):1089-92. PubMed ID: 9833191
[TBL] [Abstract][Full Text] [Related]
2. Isoform expression of CD44 adhesion molecules, Bcl-2, p53 and Ki-67 proteins in lung cancer.
Mizera-Nyczak E; Dyszkiewicz W; Heider KH; Zeromski J
Tumour Biol; 2001; 22(1):45-53. PubMed ID: 11054026
[TBL] [Abstract][Full Text] [Related]
3. Expression of CD44 variant proteins in adenocarcinoma of Barrett's esophagus and its relation to prognosis.
Böttger TC; Youssef V; Dutkowski P; Maschek H; Brenner W; Junginger T
Cancer; 1998 Sep; 83(6):1074-80. PubMed ID: 9740070
[TBL] [Abstract][Full Text] [Related]
4. Expression of CD44 variant isoforms and association to the benign form of endocrine pancreatic tumours.
Imam H; Eriksson B; Oberg K
Ann Oncol; 2000 Mar; 11(3):295-300. PubMed ID: 10811495
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of CD44 splice variants in human stage III cervical cancer.
Kainz C; Kohlberger P; Tempfer C; Sliutz G; Gitsch G; Reinthaller A; Breitenecker G
Eur J Cancer; 1995 Sep; 31A(10):1706-9. PubMed ID: 7488429
[TBL] [Abstract][Full Text] [Related]
6. CD44 and variants in melanocytic skin neoplasms.
Schaider H; Soyer HP; Heider KH; Hofmann-Wellenhof R; Zatloukal K; Smolle J; Kerl H
J Cutan Pathol; 1998 Apr; 25(4):199-203. PubMed ID: 9609138
[TBL] [Abstract][Full Text] [Related]
7. The expression of variant exon v7-v8 CD44 antigen in relation to lymphatic metastasis of human breast cancer.
Kinoshita J; Haga S; Shimizu T; Imamura H; Watanabe O; Kajiwara T
Breast Cancer Res Treat; 1999 Jan; 53(2):177-83. PubMed ID: 10326795
[TBL] [Abstract][Full Text] [Related]
8. Human mammary carcinomas express homologues of rat metastasis-associated variants of CD44.
Sinn HP; Heider KH; Skroch-Angel P; von Minckwitz G; Kaufmann M; Herrlich P; Ponta H
Breast Cancer Res Treat; 1995; 36(3):307-313. PubMed ID: 8573713
[TBL] [Abstract][Full Text] [Related]
9. Decreased levels of CD44 protein and mRNA in prostate carcinoma. Correlation with tumor grade and ploidy.
Kallakury BV; Yang F; Figge J; Smith KE; Kausik SJ; Tacy NJ; Fisher HA; Kaufman R; Figge H; Ross JS
Cancer; 1996 Oct; 78(7):1461-9. PubMed ID: 8839552
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of CD44 splice variants in human pancreatic adenocarcinoma and in normal pancreas.
Gansauge F; Gansauge S; Zobywalski A; Scharnweber C; Link KH; Nussler AK; Beger HG
Cancer Res; 1995 Dec; 55(23):5499-503. PubMed ID: 7585621
[TBL] [Abstract][Full Text] [Related]
11. Expression of CD44 standard form and variant isoforms in non-small cell lung carcinomas.
Tran TA; Kallakury BV; Sheehan CE; Ross JS
Hum Pathol; 1997 Jul; 28(7):809-14. PubMed ID: 9224749
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of the human metastasis adhesion molecule CD44V in normal and carcinomatous stomach mucosa of Chinese subjects.
Harn HJ; Ho LI; Chang JY; Wu CW; Jiang SY; Lee HS; Lee WH
Cancer; 1995 Mar; 75(5):1065-71. PubMed ID: 7531611
[TBL] [Abstract][Full Text] [Related]
13. Expression of CD44 variants in osteosarcoma.
Kuryu M; Ozaki T; Nishida K; Shibahara M; Kawai A; Inoue H
J Cancer Res Clin Oncol; 1999 Nov; 125(11):646-52. PubMed ID: 10541973
[TBL] [Abstract][Full Text] [Related]
14. Expression of CD44 isoforms in human renal cell carcinomas.
Heider KH; Ratschek M; Zatloukal K; Adolf GR
Virchows Arch; 1996 Jul; 428(4-5):267-73. PubMed ID: 8764936
[TBL] [Abstract][Full Text] [Related]
15. Expression of CD44 in duct cell carcinomas and in intraductal neoplasms of the pancreas.
Satoh K; Shimosegawa T; Koizumi M; Toyota T
Anticancer Res; 1997; 17(1A):215-9. PubMed ID: 9066654
[TBL] [Abstract][Full Text] [Related]
16. CD44 splice variant expression in normal and malignant uterine cervical epithelium.
Uhl-Steidl M; Huy VQ; Müller-Holzner E; Ruth N; Zeimet AG; Stauder R; Daxenbichler G; Marth C
Int J Gynecol Cancer; 1998; 8(6):460-6. PubMed ID: 21206358
[TBL] [Abstract][Full Text] [Related]
17. The CD44 receptor is a molecular predictor of survival in ovarian cancer.
Rodríguez-Rodríguez L; Sancho-Torres I; Mesonero C; Gibbon DG; Shih WJ; Zotalis G
Med Oncol; 2003; 20(3):255-63. PubMed ID: 14514975
[TBL] [Abstract][Full Text] [Related]
18. Decreased survival in patients with CD44-negative typical bronchial carcinoid tumors.
Granberg D; Wilander E; Oberg K; Skogseid B
Int J Cancer; 1999 Oct; 84(5):484-88. PubMed ID: 10502723
[TBL] [Abstract][Full Text] [Related]
19. Levels of v5 and v6 CD44 splice variants in serum of patients with colorectal cancer are not correlated with pT stage, histopathological grade of malignancy and clinical features.
Zalewski B
World J Gastroenterol; 2004 Feb; 10(4):583-5. PubMed ID: 14966921
[TBL] [Abstract][Full Text] [Related]
20. Expression of CD44 variants and its association with survival in pancreatic cancer.
Gotoda T; Matsumura Y; Kondo H; Saitoh D; Shimada Y; Kosuge T; Kanai Y; Kakizoe T
Jpn J Cancer Res; 1998 Oct; 89(10):1033-40. PubMed ID: 9849582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
